Oxford Nanopore Technologies, announce that bioMérieux is making an immediate £70M investment in Oxford Nanopore.

Joint development collaboration to bring leading-edge nanopore sequencing into clinical laboratories at Mayo Clinic to increase understanding and improve treatment of cancer and genetic disorders.

Study confirms ALZmetrixTM whole blood test can detect people at high risk of developing full Alzheimer’s Disease.

Global Laboratory Information Management Systems (LIMS) for the Life Sciences Industry 2023 Report benchmarked over 120 LIMS vendors and placed LabVantage in No. 1 spot for growth.

The Micro Flow Meter from Biotech Fluidics is a new device designed to continuously monitor ultra-low fluidic flows in real-time.

Magritek has made benchtop NMR suitable for the rapid identification and quantitation of analytes during chemical reactions, in batch and continuous flow processes.

The new ABLE 3D Magnetic Stir and Disposable Bioreactor System from AMSBIO provides cost-effective, lab-scale production of induced pluripotent stem (iPS) cell spheroid culture.

Research published in Molecular Cell used INDUCE-seq to identify DNA topology as an important regulator of CRISPR targeting specificity. Peer-reviewed data demonstrates the sensitivity of INDUCE-seq DNA break mapping platform.

Offering combines Revvity’s market leading reagents with SCIEX precise innovative MS/MS for labs looking to expand newborn screening capabilities.

Expanded footprint, new capabilities mark IDT’s entrance into CRISPR therapeutics space.